Gobbi M - Search Results

1

Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes.

Canovi M, Lucchetti J, Stravalaci M, Re F, Moscatelli D, Bigini P, Salmona M, Gobbi M. Canovi M, et al. Among authors: gobbi m. Sensors (Basel). 2012 Nov 27;12(12):16420-32. doi: 10.3390/s121216420. Sensors (Basel). 2012. PMID: 23443386 Free PMC article.

2

Rapid internalization of benzodiazepine receptors in the rat cortex induced by handling.

Mennini T, Gobbi M, Perin L, Salmona M. Mennini T, et al. Among authors: gobbi m. Adv Biochem Psychopharmacol. 1988;45:263-73. Adv Biochem Psychopharmacol. 1988. PMID: 2845738 No abstract available.

3

Oleamide-mediated sleep induction does not depend on perturbation of membrane homeoviscosity.

Gobbi M, Mennini T, Valle FD, Cervo L, Salmona M, Diomede L. Gobbi M, et al. FEBS Lett. 1999 Dec 17;463(3):281-4. doi: 10.1016/s0014-5793(99)01630-0. FEBS Lett. 1999. PMID: 10606738 Free article.

4

Gerstmann-Sträussler-Scheinker disease amyloid protein polymerizes according to the "dock-and-lock" model.

Gobbi M, Colombo L, Morbin M, Mazzoleni G, Accardo E, Vanoni M, Del Favero E, Cantù L, Kirschner DA, Manzoni C, Beeg M, Ceci P, Ubezio P, Forloni G, Tagliavini F, Salmona M. Gobbi M, et al. J Biol Chem. 2006 Jan 13;281(2):843-9. doi: 10.1074/jbc.M506164200. Epub 2005 Nov 10. J Biol Chem. 2006. PMID: 16286452 Free article.

5

Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.

Natalello A, Prokorov VV, Tagliavini F, Morbin M, Forloni G, Beeg M, Manzoni C, Colombo L, Gobbi M, Salmona M, Doglia SM. Natalello A, et al. Among authors: gobbi m. J Mol Biol. 2008 Sep 19;381(5):1349-61. doi: 10.1016/j.jmb.2008.06.063. Epub 2008 Jun 28. J Mol Biol. 2008. PMID: 18619462

6

Recombinant C1 inhibitor in brain ischemic injury.

Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse ML, Ziere B, Gobbi M, De Simoni MG. Gesuete R, et al. Among authors: gobbi m. Ann Neurol. 2009 Sep;66(3):332-42. doi: 10.1002/ana.21740. Ann Neurol. 2009. PMID: 19798727

7

Immunopurification of pathological prion protein aggregates.

Biasini E, Tapella L, Mantovani S, Stravalaci M, Gobbi M, Harris DA, Chiesa R. Biasini E, et al. Among authors: gobbi m. PLoS One. 2009 Nov 12;4(11):e7816. doi: 10.1371/journal.pone.0007816. PLoS One. 2009. PMID: 19915706 Free PMC article.

8

Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein.

Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T, Chiesa R, Gobbi M, Salmona M, Forloni G. Balducci C, et al. Among authors: gobbi m. Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2295-300. doi: 10.1073/pnas.0911829107. Epub 2010 Jan 19. Proc Natl Acad Sci U S A. 2010. PMID: 20133875 Free PMC article.

9

Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.

Taylor M, Moore S, Mayes J, Parkin E, Beeg M, Canovi M, Gobbi M, Mann DM, Allsop D. Taylor M, et al. Among authors: gobbi m. Biochemistry. 2010 Apr 20;49(15):3261-72. doi: 10.1021/bi100144m. Biochemistry. 2010. PMID: 20230062

10

Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.

Gobbi M, Re F, Canovi M, Beeg M, Gregori M, Sesana S, Sonnino S, Brogioli D, Musicanti C, Gasco P, Salmona M, Masserini ME. Gobbi M, et al. Biomaterials. 2010 Sep;31(25):6519-29. doi: 10.1016/j.biomaterials.2010.04.044. Biomaterials. 2010. PMID: 20553982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

741 results

Search Page